Context Investigational Site is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Context Investigational Site has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Mesothelin-Expressing Tumors, Epithelial Ovarian Cancer, Malignant Pleural Mesothelioma, Advanced.
Sponsors: Context Therapeutics Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Context Investigational Site has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Context Investigational Site has 1 clinical trials on record, with 1 currently active. Their work covers Mesothelin-Expressing Tumors, Epithelial Ovarian Cancer, Malignant Pleural Mesothelioma, Advanced.
Context Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.